Skip to main content

Oteseconazole use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Jun 16, 2023.

Drugs containing Oteseconazole: Vivjoa

Oteseconazole Levels and Effects while Breastfeeding

Summary of Use during Lactation

Oteseconazole must not be used by women of reproductive potential because of the possibility of fetal harm. It is extremely long-lasting and could remain in the milk for as long as 2 years after a course of therapy. An alternate drug should be used.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Clotrimazole, Fluconazole, Miconazole, Nystatin

Substance Identification

Substance Name

Oteseconazole

CAS Registry Number

1340593-59-0

Drug Class

Breast Feeding

Lactation

Milk, Human

Antifungal Agents

Dermatologic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.